| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 12/25/2013 | CN103463083A Method for treating or preventing thrombosis using dabigatran etexilate or a salt thereof with improved efficacy over conventional warfarin therapy |
| 12/25/2013 | CN103463081A Peritoneal dialysis solution |
| 12/25/2013 | CN103462985A Application of spirooliganones B in preparation of medicine inhibiting platelet aggregation |
| 12/25/2013 | CN103462956A Application of Nardoaristolones A in preparation of medicaments for increasing erythrocytes |
| 12/25/2013 | CN103462916A Vitamin C chewable tablet and preparation method thereof |
| 12/25/2013 | CN103462911A Preparation technique of freeze-dried powder injection |
| 12/25/2013 | CN102973520B Diethylamide ethylenediamine compound-containing drug composition |
| 12/25/2013 | CN102824417B New method for treating helicobacter pylori related diseases |
| 12/25/2013 | CN102796197B Human serum albumin-granulocyte colony stimulating factor (HAS-GCSF) mutant and preparation method thereof |
| 12/25/2013 | CN102716255B Eucommia ulmoides medicinal wine and preparation method thereof |
| 12/25/2013 | CN102641480B Traditional Chinese medicine composite used for treating microcirculation disturbance and preparation method thereof |
| 12/25/2013 | CN102631584B Traditional Chinese medicine composition for treating idiopathic thrombocytopenic purpura |
| 12/25/2013 | CN102532297B Ancylostoma caninum anticoagulant peptide and preparation and application thereof |
| 12/25/2013 | CN102462730B Traditional Chinese medicine composition for treating tumors |
| 12/25/2013 | CN102416171B Protective agent in process for performing dry heat virus inactivation on high-purity prothrombin complex concentrate products |
| 12/25/2013 | CN102174046B Tetomilast polymorphs |
| 12/25/2013 | CN102091345B Sodium alga acid composition and application thereof |
| 12/24/2013 | US8614244 Spot-on pesticide composition |
| 12/24/2013 | US8614204 Enhanced erythropoiesis and iron metabolism |
| 12/24/2013 | US8613909 Cinnamic acid-based oligomers and uses thereof |
| 12/24/2013 | CA2393816C Process for obtaining thylakoids from photosynthetic organisms; plant fractions obtained from the process; pure thylakoids; and methods of use of thylakoids as ros scavengers, photo-protectors, biosensors, biofilters and bioreactors |
| 12/19/2013 | WO2013188258A1 Use of hmb to improve health outcomes for hospitalized patients |
| 12/19/2013 | WO2013187396A1 Separation membrane for blood treatment and blood treatment device having same membrane incorporated therein |
| 12/19/2013 | US20130337950 Blood-Trail Enhancer for Bow Hunting |
| 12/19/2013 | US20130337041 Charged phospholipid compositions and methods for their use |
| 12/18/2013 | EP2674165A2 Hepatocyte growth factor receptor agonist for increasing lymphangiogenesis |
| 12/18/2013 | EP2672976A1 Idrabiotaparinux for the treatment of pulmonary embolism and for the secondary prevention of venous thromboembolic events |
| 12/18/2013 | EP2672965A2 Treatment and prevention of cardiovascular disease and thrombosis |
| 12/18/2013 | CN103451172A Modified factor vii polypeptides and uses thereof |
| 12/18/2013 | CN103450371A Tetrahydro-beta-carbolinyl-3-formacyl-diethylenetriamino-beta-cyclodextrins, and preparation, antithrombotic activity and application thereof |
| 12/18/2013 | CN103450349A Polyasparacyl oligopeptides with chain length of 119, and preparation method, thrombolytic effect, nano-structure and application thereof |
| 12/18/2013 | CN103450348A Mimetic peptide of erythropoietin, preparation method and applications thereof |
| 12/18/2013 | CN103450344A Tetrahydroisoquinolinyl-3-carboxylic acid modified LARGD heptapeptides, and synthesis, antithrombotic activity and application thereof |
| 12/18/2013 | CN103450343A Tetrahydroisoquinolinyl-3-carboxylic acid modified TARGD heptapeptides, and synthesis, antithrombotic activity and application thereof |
| 12/18/2013 | CN103450342A Tetrahydroisoquinolinyl-3-carboxylic acid modified PARGD heptapeptides, and synthesis, antithrombotic activity and application thereof |
| 12/18/2013 | CN103450339A LRGD peptide-modified carbolino-hexahydropyrazine-1,4-diketones and their preparation method, antithrombotic effect and use |
| 12/18/2013 | CN103450337A TRGD peptide-modified carbolino-hexahydropyrazine-1,4-diketones and their preparation method, antithrombotic effect and use |
| 12/18/2013 | CN103450336A KRGD peptide-modified carbolino-hexahydropyrazine-1,4-diketones and their preparation method, antithrombotic effect and use |
| 12/18/2013 | CN103450334A RGD peptide-modified carbolino-hexahydropyrazine-1,4-diketones and their preparation method, antithrombotic effect and use |
| 12/18/2013 | CN103450333A 1,1-dimethyl-beta-carboline carboxylic acid-modified RGD peptides and their synthesis, anti-thrombus effect and use |
| 12/18/2013 | CN103450330A Dihydroxyltetrahydroisoquinoline-3-formyl amino acids as well as synthesis, antithrombotic effect and application thereof |
| 12/18/2013 | CN103450214A Glucopyranesyl derivative, preparation method thereof and application thereof in medicines |
| 12/18/2013 | CN103450197A Cyclohexyl tetrahydro imidazo pyrido indole-diketone acetyl amino acids, and synthesis, antithrombotic effect and application thereof |
| 12/18/2013 | CN103450196A AGDV peptide modified carboline-hexahydropyrazine-1,4-dione, preparation method, antithrombotic effect, and applications thereof |
| 12/18/2013 | CN103450110A Pharmaceutical composition containing optically active compound having thrombopoietin receptor agonist activity and intermediate thereof |
| 12/18/2013 | CN103450087A Preparation method of paeonol and ozagrel conjugate |
| 12/18/2013 | CN103450086A Ozagrel compound, preparation method and pharmaceutical composition of ozagrel compound |
| 12/18/2013 | CN103450067A Bi[indole-3-yl-acetylamino acid] connected by ethyl, preparation method, antithrombotic function, and applications thereof |
| 12/18/2013 | CN103446589A Tetrahydro-beta-carbolinyl-3- formyl-diethylenetriamino-beta-cyclodextrin copper complex, and preparation, antithrombotic action and application thereof |
| 12/18/2013 | CN103446584A Method of treating hemolytic disease |
| 12/18/2013 | CN103446579A Antidotes for factor xa inhibitors and methods of using the same |
| 12/18/2013 | CN103446569A Formula and preparation method of astaxanthin with thrombolysis effect |
| 12/18/2013 | CN103446568A Chinese medicine oral liquid for treating swine hemorrhagic anemia and preparation method thereof |
| 12/18/2013 | CN103446511A Oral sharpleaf galangal fruit solution |
| 12/18/2013 | CN103446497A Production process of compound wine for tonifying kidney and producing sperms of men and improving memory |
| 12/18/2013 | CN103446479A Traditional Chinese medicine for treating alar acute purulent lymphadenitis caused by overeating fried food |
| 12/18/2013 | CN103446469A Preparation method of pinellia rhizome fermented mass |
| 12/18/2013 | CN103446438A Preparation method of traditional Chinese medicine for treating constipation-type alar acute purulent lymphadenitis |
| 12/18/2013 | CN103446420A Traditional Chinese medicine composition for treating liver and kidney deficiency |
| 12/18/2013 | CN103446383A Product prepared from American ginseng and donkey-hide gelatin dices and preparation method thereof |
| 12/18/2013 | CN103446363A Externally applied medicine for treating hemorrhoids and preparation method of externally applied medicine |
| 12/18/2013 | CN103446327A Antianemic oral liquid and preparation technology thereof |
| 12/18/2013 | CN103446323A Traditional Chinese medicine composition for treating hemolytic anemia |
| 12/18/2013 | CN103446267A Traditional Chinese medicine composition for treating upper gastrointestinal hemorrhage |
| 12/18/2013 | CN103446248A Lotus root plant total extract-containing dripping pills and preparation method thereof |
| 12/18/2013 | CN103446234A Multi-variant and multi-phase salvia miltiorrhiza solid self-microemulsion, application thereof in preparation of drug and preparation method thereof |
| 12/18/2013 | CN103446205A Composition for prevention and treatment of chemoradiotherapy induced leukopenia and its application |
| 12/18/2013 | CN103446195A Preparation method of ginkgo biloba extract |
| 12/18/2013 | CN103446184A Application of amniotic mesenchymal stem cells in preparation of medicine for prolonging life, health product or cosmetic |
| 12/18/2013 | CN103446181A Preparation process of peritoneal dialysate with physiologic pH value |
| 12/18/2013 | CN103446156A Application of caffeine in preparing anticoagulation medicine |
| 12/18/2013 | CN103446155A mTOR (Mammalian Target Of Rapamycin) inhibitor and use thereof |
| 12/18/2013 | CN103446120A Application of Fluevirosines A in preparation of anti-platelet aggregation drug |
| 12/18/2013 | CN103446082A Application of salvianolic acid B to preparation of medicament for prevention and / or treatment of pulmonary microcirculation disorder or lung injury |
| 12/18/2013 | CN103446061A Developing nano-silver sodium alginate microsphere vascular embolizing agent and preparation method thereof |
| 12/18/2013 | CN103446057A Oral curcumin nano-granule and preparation method thereof |
| 12/18/2013 | CN103446048A Famotidine injection and preparation method thereof |
| 12/18/2013 | CN103446045A Stable busulfan injection |
| 12/18/2013 | CN102839108B Functional ginseng health care liquor and preparation method thereof |
| 12/18/2013 | CN102716154B Processing method and product of ionized calcium water-solubility preparation |
| 12/18/2013 | CN102688426B Traditional Chinese medicine composition for treating acute upper gastrointestinal hemorrhage, as well as preparation method and application thereof |
| 12/18/2013 | CN102688368B Traditional Chinese medicine for treating trauma hemostasis or telephium |
| 12/18/2013 | CN102579576B Chuanxiongchatiao granule extracts and preparations thereof |
| 12/18/2013 | CN102477034B 1-methyl-beta-carboline-3-carboxylic acid modified by amino acid as well as synthesizing method and application thereof |
| 12/18/2013 | CN102432624B Preparation technology for crystal of dithiole pyrrolones compound |
| 12/18/2013 | CN102397593B Embolization particles developable under X-rays and preparation method and application thereof |
| 12/18/2013 | CN102343007B Traditional Chinese medicine composition with hemostasis function |
| 12/18/2013 | CN102321129B Stilbene glycoside injection and preparation process thereof |
| 12/18/2013 | CN102088978B Ameliorating or therapeutic agent for dyslipidemia |
| 12/17/2013 | US8609646 Enhanced erythropoiesis and iron metabolism |
| 12/17/2013 | US8609126 Methods and compositions for treating post-myocardial infarction damage |
| 12/17/2013 | CA2668068C Combination therapy of substituted oxazolidinones |
| 12/17/2013 | CA2648503C Method for producing high-purity prasugrel or an acid addition salt thereof |
| 12/17/2013 | CA2504401C Drug delivery systems for the prevention of neointimal hyperlasia |
| 12/17/2013 | CA2478855C Use of il-18 inhibitors for the treatment and/or prevention of peripheral vascular diseases |
| 12/12/2013 | WO2013185113A1 Procoagulant compounds |
| 12/12/2013 | WO2013184734A1 Macrocyclic factor viia inhibitors |
| 12/12/2013 | US20130331310 Prodrug of an Ice Inhibitor |
| 12/12/2013 | US20130330357 METHODS OF TREATING DISORDERS USING HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha |
| 12/12/2013 | US20130330356 METHODS OF TREATING DISORDERS USING HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha |